Skip to content
Search

Latest Stories

UKPPLAB to elevate pharmacist satisfaction and enhance patient safety

UKPPLAB to elevate pharmacist satisfaction and enhance patient safety
PDA advocates pharmacist autonomy in professional leadership amid CPhO influence

In a bid to bolster professional leadership within the pharmacy sector, the four government Chief Pharmaceutical Officers (CPhOs) have embarked on a significant initiative, forming the UK Pharmacy Professional Leadership Advisory Board (UKPPLAB).

In a recent communication, all pharmacists and pharmacy technicians received confirmation of the board members selected by the CPhOs, alongside a note from the board's appointed chair, who was chosen collectively by the four CPhOs and reports directly to the CPhO for England.


Over three years, the 21-member Board will implement recommendations from the UK Commission on Pharmacy Professional Leadership’s report aimed to enhance professional fulfillment among pharmacists while simultaneously augmenting patient safety standards.

This announcement also follows with the appointment of Sir Hugh Taylor as its Independent Chair and the appointment of Independent Expert Members who expressed his delight over the role's "potential to lead and support collaboration across the professions in the UK".

However, the move has been met with cautious optimism from the Pharmacists' Defence Association (PDA), urging the new board to uphold transparency and openness to garner trust among pharmacists.

The introduction of this government-backed initiative lies in the recommendations of a commission funded by the government, wherein the CPhOs played a pivotal role.

Serving as advisors, selectors, and recipients of the commission's final report, the CPhOs have now taken the reins in creating a leadership advisory board.

The composition of the UKPPLAB underscores the involvement of the CPhOs in selecting the board's chair, participating in interviews, and endorsing independent board members, whose remuneration will be facilitated by the NHS.

While acknowledging the stature of the four CPhOs within the NHS, the PDA emphasizes the need for pharmacists to have a decisive say in their professional leadership, separate from employer or governmental influence.

A critical point of contention raised by the PDA is related to transparency in the selection process and concerns have been voiced regarding the association of board members with specific organizations and the lack of clarity regarding their roles and affiliations.

The PDA advocates for full disclosure of interests, remuneration arrangements, and organizational affiliations of all board members to ensure transparency and accountability.

In light of these concerns, the PDA has also called for greater transparency, urging the publication of eligibility criteria, membership statistics, and funding sources for organizations represented on the board.

Additionally, individual board members are urged to declare their interests comprehensively to provide stakeholders with a clear understanding of the board's composition and potential influences underscoring the necessity for transparency and accountability in shaping the future of pharmacy practice in the UK.

More For You

Royal College status: The PDA calls for ‘meaningful and collaborative dialogue’

The profession’s success will depend on collaboration across all sectors, says PDA.

gettyimages

Royal College vote: Less than 7% of GB pharmacists in favour, says PDA

The Pharmacists’ Defence Association (PDA) has criticised the Royal Pharmaceutical Society (RPS) for moving too quickly to a ballot on its proposed transition to a Royal College, arguing that it resulted in low participation from pharmacists in Great Britain.

Announcing the results of the special resolution vote, the RPS said that the outcome was a “clear mandate” in favour of the transformative change.

Keep ReadingShow less
RPS Wales calls for urgent investment in pharmacy workforce at Senedd meeting

Third from the left: Eluned Morgan, First Minister of Wales

Photo credit: RPS

Invest in pharmacy workforce: RPS Wales urges Senedd members

Members of the Senedd (MSs) were briefed on the increasing pressures facing pharmacy teams and the urgent need for action to support their health and wellbeing at an event hosted by the Royal Pharmaceutical Society (RPS) Wales.

The event, held on Wednesday, brought together MSs, including first minister Eluned Morgan, to discuss the findings of RPS’ latest Workforce Wellbeing Survey.

Keep ReadingShow less
Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less